Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Seminars in Arthritis and Rheumatism|March 26, 2026
Sex differences in patient-reported outcome measures and clinical parameters in patients with Sjögren's diseaseHelene Kokol, Dagmar Rebel, Liseth de Wolff, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Differences in presentation between paediatric- and adult-onset primary Sjögren's syndrome patientsGeertje E Legger, Margit B Erdtsieck, Liseth de Wolff, et al.
Rheumatology (Oxford, England)|October 21, 2021
Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sjögren's syndromeEsther Mossel, Martha S van Ginkel, Erlin A Haacke, et al.
RMD Open|August 14, 2024
More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren's diseaseGeertje Elizabeth Legger, Uzma Nakshbandi, Martha S van Ginkel, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2014
Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjectsByrthe J P R Vos, Eveline van der Veer, Pieter C van Voorst Vader, et al.
Seminars in Arthritis and Rheumatism|January 29, 2022
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trialLiseth de Wolff, Jolien F van Nimwegen, Esther Mossel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2023
Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are IncludedMartha S van Ginkel, Uzma Nakshbandi, Suzanne Arends, et al.
The Lancet. Rheumatology|January 30, 2024
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measureSuzanne Arends, Liseth de Wolff, Jolien F van Nimwegen, et al.
Seminars in Arthritis and Rheumatism|June 11, 2026
OMERACT- determining a core domain set for Sjögren's disease: International focus group seriesDana D DiRenzo, Lee Ang, Caroline O'Brien, et al.
The Lancet. Rheumatology|January 24, 2024
Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)Jolien F van Nimwegen, Esther Mossel, Greetje S van Zuiden, et al.
Pageof 14